Medico Intercontinental

Medico Intercontinental Current Assets

The Current Assets of Medico Intercontinental (539938.BO) as of Oct 27, 2026 is 565.77 M INR. In the previous year, Current Assets was 384.83 M INR — a change of 47.02% (higher).

Current Assets

565.77 MINR

YoY

47.02%

Last updated:

Current Assets of Medico Intercontinental is 2025 565.77 M INR. Current Assets of Medico Intercontinental was 2024 384.83 M INR. It decreases by 47.02% higher compared to the previous year.

The Medico Intercontinental Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
15.17 M INR
Jan 1, 2019
83.21 M INR
Jan 1, 2020
340.24 M INR
Jan 1, 2022
123.36 M INR
Jan 1, 2023
497.03 M INR
Jan 1, 2024
384.83 M INR
Jan 1, 2025
565.77 M INR
The Medico Intercontinental Current Assets history
YEARCurrent AssetsYoY
565.77 MINR+47.02%
384.83 MINR-22.57%
497.03 MINR+302.90%
123.36 MINR-63.74%
340.24 MINR+308.92%
83.21 MINR+448.56%
15.17 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medico Intercontinental Stock analysis

What does Medico Intercontinental do? Medico Intercontinental Ltd. generates revenue through financing, trading, and investment in shares and securities. The company provides a platform for research-based biopharmaceutical companies, focusing on product categories such as gastro, uro, nutrition, cosmetology, health devices, and hospital services. Its product portfolio includes ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, and other branded pharmaceuticals like CYCLOFACT 400, UDIFACT 150, and ZIFT SL - 250. Subsidiaries such as Evagrace Pharma Private Limited and Ritz Formulations Private Limited support its operations in the biopharmaceutical sector. The company serves biopharmaceutical firms seeking research-based solutions, with products distributed across gastroenterology, urology, nutrition, and cosmetology segments. Key brands like ALFACARE - D3, ARSUFACT Combokit, and BALOFACT target specific medical needs, while health devices and hospital-related products cater to broader healthcare markets. Subsidiaries like Sungrace Pharma Private Limited and Azillian Healthcare Private Limited contribute to the company's product development and market reach. Medico Intercontinental Ltd. monetizes its platform by facilitating trading and investment activities in securities, alongside its biopharmaceutical product sales. The company's subsidiaries manage production and distribution of branded pharmaceuticals, ensuring market presence in key healthcare segments. Products such as RELIEVE CZ, VOLIREX SPRAY, and ZYMIX SY are sold to healthcare providers and consumers in the biopharmaceutical industry. Medico Intercontinental is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medico Intercontinental stock

Current Assets of Medico Intercontinental is 565.77 M INR in 2025.

Current Assets of Medico Intercontinental changed from 384.83 M INR to 565.77 M INR, representing a 47.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Medico Intercontinental since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Medico Intercontinental historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Medico Intercontinental

All Key Metrics — Medico Intercontinental